Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study

被引:12
作者
Engen, Magnus Johan [1 ,2 ]
Vaskinn, Anja [3 ,4 ]
Melle, Ingrid [3 ,5 ]
Faerden, Ann [6 ]
Lyngstad, Siv Hege [1 ]
Flaaten, Camilla Barthel [2 ,5 ]
Widing, Line Hustad [3 ,5 ]
Wold, Kristin Fjelnseth [3 ]
Asbo, Gina [2 ,5 ]
Haatveit, Beathe [3 ,5 ]
Simonsen, Carmen [7 ]
Ueland, Torill [2 ,3 ,5 ]
机构
[1] Oslo Univ Hosp, Div Mental Hlth & Addict, Nydalen DPS, Oslo, Norway
[2] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Norwegian Ctr Mental Disorders Res NORMENT, Oslo, Norway
[4] Oslo Univ Hosp, Ctr Res & Educ Forens Psychiat, Oslo, Norway
[5] Oslo Univ Hosp, Div Mental Hlth & Addict, Sect Psychosis Res, Oslo, Norway
[6] Oslo Univ Hosp, Dept Acute Psychiat, Div Mental Hlth & Addict, Oslo, Norway
[7] Oslo Univ Hosp, Div Mental Hlth & Addict, Early Intervent Psychosis Advisory Unit South East, Oslo, Norway
关键词
cognition; longitudinal; negative symptoms (schizophrenia); attention; processing speed; executive functions; global functioning; 1ST EPISODE PSYCHOSIS; SYNDROME SCALE; NEUROCOGNITIVE DEFICITS; 5-FACTOR MODEL; DRUG-USE; SCHIZOPHRENIA; TRAJECTORIES; GENERALIZABILITY; METAANALYSIS; RELIABILITY;
D O I
10.3389/fpsyt.2022.841057
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Negative and cognitive symptoms are core features of schizophrenia that are correlated in cross-sectional designs. To further explore the relationship between these critical symptom dimensions we use a method for stratifying participants based on level and persistence of negative symptoms from absent to sustained levels over a 10-year follow-up period. We investigate associations with cognitive performance and level of global functioning. First-episode psychosis (FEP) participants (n = 102) and healthy controls (n = 116) were assessed at baseline and follow-up. A cognitive battery consisting of 14 tests derived into four domains and a composite score were used in the analyses. FEP participants were stratified based on negative symptom items from the Positive and Negative Syndrome Scale (PANSS-R) into four groups with either no, mild, transitory or sustained symptoms over the 10-year follow-up period. Global functioning was measured with Global Assessment of Functioning Scale-Split version. Multivariate and univariate analyses of variance were used to explore between-group differences in level and course of cognitive performance as global functioning. A multivariate analysis with four cognitive domains as dependent variables, showed significant group differences in performance when including healthy controls and the negative symptom groups. The groups with no and mild negative symptoms outperformed the group with sustained levels of negative symptoms on verbal learning and memory. The group with no negative symptoms also outperformed the group with sustained negative symptoms on the cognitive composite score. Significant improvements on verbal learning and memory, executive functioning and the cognitive composite were detected for the entire sample. No differences in cognitive course were detected. There was a significant improvement in global functioning as measured by the GAF-F over the follow-up period (p < 0.001), without any time x group interactions (p = 0.25). Participants with sustained negative symptoms had a significantly lower level of global functioning at 10-year follow-up with an additional independent effect of the cognitive composite score, compared to all other groups. Individuals with an early illness course characterized by absence of negative symptoms form a group with better cognitive and functional outcomes than the impairments typically associated with schizophrenia. Individuals with sustained levels of negative symptoms on the other hand may require a combined focus on both negative and cognitive symptoms.
引用
收藏
页数:13
相关论文
共 57 条
[1]   RELIABILITY AND VALIDITY OF A DEPRESSION RATING-SCALE FOR SCHIZOPHRENICS [J].
ADDINGTON, D ;
ADDINGTON, J ;
MATICKATYNDALE, E ;
JOYCE, J .
SCHIZOPHRENIA RESEARCH, 1992, 6 (03) :201-208
[2]  
Aleman A, 1999, AM J PSYCHIAT, V156, P1358
[3]   Remission in schizophrenia: Proposed criteria and rationale for consensus [J].
Andreasen, NC ;
Carpenter, WT ;
Kane, JM ;
Lasser, RA ;
Marder, SR ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) :441-449
[4]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
[5]  
[Anonymous], 1997, WDSCALE WAI 3 WAIS 3
[6]   Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10 year follow-up study in the OPUS cohort [J].
Austin, Stephen F. ;
Mors, Ole ;
Budtz-Jorgensen, Esben ;
Secher, Rikke Gry ;
Hjorthoj, Carsten R. ;
Bertelsen, Mette ;
Jeppesen, Pia ;
Petersen, Lone ;
Thorup, Anne ;
Nordentoft, Merete .
SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) :84-91
[7]   Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis and First-Episode Psychosis: Do the Cognitive Deficits Progress Over, or After, the Onset of Psychosis? [J].
Bora, Emre ;
Murray, Robin M. .
SCHIZOPHRENIA BULLETIN, 2014, 40 (04) :744-755
[8]   Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition [J].
Bucci, P. ;
Galderisi, S. ;
Mucci, A. ;
Rossi, A. ;
Rocca, P. ;
Bertolino, A. ;
Aguglia, E. ;
Amore, M. ;
Andriola, I. ;
Bellomo, A. ;
Biondi, M. ;
Cuomo, A. ;
dell'Osso, L. ;
Favaro, A. ;
Gambi, F. ;
Giordano, G. M. ;
Girardi, P. ;
Marchesi, C. ;
Monteleone, P. ;
Montemagni, C. ;
Niolu, C. ;
Oldani, L. ;
Pacitti, F. ;
Pinna, F. ;
Roncone, R. ;
Vita, A. ;
Zeppegno, P. ;
Maj, M. .
ACTA PSYCHIATRICA SCANDINAVICA, 2018, 138 (03) :253-266
[9]   Persistent negative symptoms in schizophrenia: An overview [J].
Buchanan, Robert W. .
SCHIZOPHRENIA BULLETIN, 2007, 33 (04) :1013-1022
[10]  
CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578